Scancell Holdings

SCLP · AIM · Health Care · mcap £129m · 9.3p

Beta Briefing, track record and bull & bear case are not ready for Scancell Holdings yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 29 companies are already wired into a briefing: browse them.

Financials · LTM to 30 Apr 26

Source: results 09 Oct 26 ↗

Going-concern uncertainty

Revenue: £0k
Operating profit: −£17.4m
Net income: −£17.9m
Free cash flow: −£11.3m
Net debt: £11.5m
Market cap: £113m
EV / EBIT: –
FCF yield: −10.0%
Price / book: –

Latest half-year · H1 Oct 25 vs H1 Oct 24 results 29 Jan 26 ↗

Operating profit: −£8.9m
Net income: −£5.7m
Cash from operations: −£7.2m

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: FY Apr 26 (twelve months to 30 Apr 26), published 09 Oct 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	FY Apr 26	FY Apr 25
Revenue	0.0	4.7
Gross profit	0.0	4.5
Operating profit	(17.4)	(15.0)
Depreciation (owned assets)	0.3	0.5
Depreciation (right-of-use)	0.4	0.4
Share-based payments	1.8	1.4
Finance costs	(2.0)	(1.7)
Profit before tax	(20.2)	(15.3)
Tax	2.3	3.0
Net income (owners)	(17.9)	(12.3)
EPS basic	(1.7p)	(1.3p)
EPS diluted	(1.7p)	(1.3p)

	H2 Apr 26	H1 Oct 25	H2 Apr 25	H1 Oct 24
Operating profit	(8.5)	(8.9)	(4.5)	(10.5)
Depreciation (owned assets)	(0.1)	0.4	0.0	0.5
Share-based payments	0.7	1.1	0.9	0.5
Finance costs	(1.0)	(1.0)	(0.9)	(0.8)
Profit before tax	(13.4)	(6.8)	(1.5)	(13.8)
Tax	1.3	1.1	1.7	1.3
Net income (owners)	(12.2)	(5.7)	0.2	(12.5)
EPS basic	(1.2p)	(0.6p)	0.1p	(1.4p)
EPS diluted	(1.1p)	(0.6p)	0.1p	(1.4p)

	FY Apr 26	FY Apr 25
Cash from operations	(10.8)	(6.4)
Interest paid	(0.1)	(0.0)
Capex (PP&E)	0.0	(0.0)
Capex (intangibles)	(0.1)	(1.5)
Lease principal paid	(0.4)	(0.4)
Shares issued	0.0	11.3

	H2 Apr 26	H1 Oct 25	H2 Apr 25	H1 Oct 24
Cash from operations	(3.6)	(7.2)	(1.4)	(5.0)
Interest paid	(0.0)	(0.1)	(0.0)	(0.0)
Capex (PP&E)	0.0	0.0	(0.0)	0.0
Capex (intangibles)	(0.0)	(0.1)	(1.3)	(0.2)
Lease principal paid	(0.2)	(0.2)	(0.2)	(0.2)
Shares issued	0.0	0.0	11.3	0.0

	FY Apr 26	FY Apr 25
Other intangibles	1.6	1.6
Property, plant & equipment	0.1	0.4
Trade receivables	0.7	0.6
Cash	5.3	16.9
Current assets	8.4	20.6
Total assets	10.4	23.1
Trade payables	4.3	3.2
Borrowings, current	16.8	15.8
Lease liabilities, current	0.2	0.4
Current liabilities	29.7	26.8
Lease liabilities, non-current	0.0	0.1
Total liabilities	29.8	26.9
Total equity	(19.4)	(3.8)

	H2 Apr 26	H1 Oct 25	H2 Apr 25	H1 Oct 24
Other intangibles	1.6	1.6	1.6	1.5
Property, plant & equipment	0.1	0.2	0.4	0.6
Trade receivables	0.7	0.5	0.6	0.6
Cash	5.3	8.6	16.9	9.1
Current assets	8.4	13.3	20.6	13.8
Total assets	10.4	15.4	23.1	16.6
Trade payables	4.3	3.1	3.2	4.5
Borrowings, current	16.8	15.9	15.8	14.8
Lease liabilities, current	0.2	0.3	0.4	0.4
Current liabilities	29.7	23.7	26.8	31.8
Lease liabilities, non-current	0.0	0.0	0.1	0.3
Total liabilities	29.8	23.7	26.9	32.1
Total equity	(19.4)	(8.4)	(3.8)	(15.5)

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.